过氧体功能障碍和脂肪性肝病
Navia Vinoy1,2, Gary Huang1,2, Daniel F Wallace2,3
1Hepatogenomics Research Group, Queensland University of Technology (QUT), Brisbane, QLD 4059, Australia.
International journal of molecular sciences
|September 13, 2025
概括
过氧体缺陷可能会导致与代谢功能障碍相关的脂肪性肝病 (MASLD). 本综述探讨了过氧体功能障碍与MASLD的发展之间的潜在联系.
科学领域:
- 细胞生物学 细胞生物学
- 代谢障碍 代谢障碍 代谢障碍
- 肝病学 肝病学是一种肝病学.
背景情况:
- 过氧体是脂质代谢和活性氧物种排毒的重要器官.
- 过氧体疾病是由遗传缺陷引起的,导致各种临床表现,包括肝脏问题.
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的全球健康问题.
研究的目的:
- 调查过氧体功能障碍在MASLD病变发生过程中的潜在作用.
- 审查当前对过氧体疾病及其与肝脏疾病的联系的理解.
- 为突出未来研究过氧体-MASLD相互作用的领域.
主要方法:
- 关于过氧体疾病和MASLD的文献综述.
- 对分子机制的分析,将过氧体功能与肝脏健康联系起来.
- 综合证据证明过氧体参与MASLD的发展.
主要成果:
- 过氧体缺陷可能导致与肝硬化相关的代谢障碍.
- 特定的过氧体酶和生物生成途径与脂质代谢有关.
- 证据表明,受损的过氧体功能和MASLD病变发生之间存在可信的联系.
结论:
- 过氧体功能障碍可能是导致MASLD的潜在因素.
- 需要进一步的研究来阐明精确的机制,连接过氧体和MASLD.
- 了解这种联系可能为MASLD提供新的治疗点.
更多相关视频
相关概念视频
Protein Import into the Peroxisomes
5.3K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.3K
Peroxisomes
20.0K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
20.0K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
215
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
215
Inborn Errors of Metabolism
697
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
697
Overview of Lipid Metabolism
4.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.9K


